Mereo Biopharma Group PLC
NASDAQ:MREO

Watchlist Manager
Mereo Biopharma Group PLC Logo
Mereo Biopharma Group PLC
NASDAQ:MREO
Watchlist
Price: 3.82 USD -5.68% Market Closed
Market Cap: 583.7m USD
Have any thoughts about
Mereo Biopharma Group PLC?
Write Note

Mereo Biopharma Group PLC
Net Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Mereo Biopharma Group PLC
Net Income Peer Comparison

Comparables:
CNTA
AUTL
BCYC
IMCR
GNS

Competitive Net Income Analysis
Latest Figures & CAGR of Competitors

Company Net Income CAGR 3Y CAGR 5Y CAGR 10Y
Mereo Biopharma Group PLC
NASDAQ:MREO
Net Income
-ÂŁ34.6m
CAGR 3-Years
41%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Net Income
-$151.1m
CAGR 3-Years
-142%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Autolus Therapeutics PLC
NASDAQ:AUTL
Net Income
-$208.4m
CAGR 3-Years
-14%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bicycle Therapeutics PLC
NASDAQ:BCYC
Net Income
-$166.3m
CAGR 3-Years
-36%
CAGR 5-Years
-38%
CAGR 10-Years
N/A
Immunocore Holdings PLC
NASDAQ:IMCR
Net Income
-ÂŁ55.3m
CAGR 3-Years
9%
CAGR 5-Years
5%
CAGR 10-Years
N/A
Genus PLC
LSE:GNS
Net Income
ÂŁ2.4m
CAGR 3-Years
-63%
CAGR 5-Years
-19%
CAGR 10-Years
-22%

See Also

What is Mereo Biopharma Group PLC's Net Income?
Net Income
-34.6m GBP

Based on the financial report for Dec 31, 2023, Mereo Biopharma Group PLC's Net Income amounts to -34.6m GBP.

What is Mereo Biopharma Group PLC's Net Income growth rate?
Net Income CAGR 3Y
41%

Over the last year, the Net Income growth was 4%. The average annual Net Income growth rates for Mereo Biopharma Group PLC have been 41% over the past three years .

Back to Top